EUVIMED · CrossrefZeitschrift
Current Opinion on Therapeutic Patents
ISSN 0962-2594 · Informa Healthcare
Neueste Artikel
Patent News
Overview: Recent Developments in Anticancer Agents
Patent Evaluation: Analogues of Leutinizing Hormone-Releasing Hormone in the Treatment of Prostate and Breast Cancer
Patent Evaluation: An Orally-Active Gold Complex for the Treatment of Leukaemia
Patent Evaluation: N-(3-alkyliminooxy- and N-(3-aminooxy- 2-fluoropropyl) Alkylamines as Ornithine Decarboxylase Inhibitors
Patent News
Overview: Novel Analogues of Mineralocorticoids, Antimineralocorticoids and Related Compounds
Patent Evaluation: Novel Naphthyridine and Pyridopyrazine Derivatives as Anti-Allergy Agents
Patent Evaluation: An Anhydrous, Crystalline form of Tenidap as an Anti-Inflammatory Agent
Patent Evaluation: Quinolinyl-Benzoheterobicyclic Derivatives as LTD 4 Antagonists
Patent Evaluation: Agents which Interfere with IL-1 for the Treatment of Arthritis
Patent News
Patent Update: Antibacterial Patents Appearing in the Third Quarter of 1991
Patent Evaluation: Highly Potent Carbapenems Resistant to DHP-I
Patent Evaluation: Novel Prodrugs for the Treatment of PCP
Patent Evaluation: Artemisinin Analogues as Potential Antimalarial Agents
Patent Evaluation: Acyclic Phosphonate Nucleotide Analogues as Highly Potent Antivirals
Patent News
Overview: Recent Aspects of Transgene Technology
Patent Update: Adhesion Molecules: Mediators of Inflammation and the Immune System
Patent Update: Yeast Expression Systems
Patent Evaluation: A Method for the Detection of Point Mutations
Patent Evaluation: A New Approach to the Production of Human Monoclonal Antibodies
Patent Evaluation: Autoantibodies to CD43 as a Target for HIV Diagnosis
Patent News
Patent Update: Adenosine Antagonists
Patent Evaluation: Urethanes and O-methyloximes of 3-formyl-1,2,5,6-tetrahydropyridine as ACh Agonists
Patent Evaluation: Novel N-benzylpiperidino-Substituted Tricyclic Amines for the Treatment of Memory Disorders
Patent Evaluation: Novel N-cycloalkylamines as Sigma Agonists
Patent News
EUVIMED